Norwegian Cruise Lines rises to become the best performing stock in the S&P 500 index.

ACI-7104 Phase 2 data and mid-2026 readout, plus FY25 cash burn and dilution risk—see key catalysts and what to do now.

Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...

The FDA is working to replace animal testing in drug development with alternative methods, aiming to be more ethical and potentially faster.

Liège-based Bio‑Sourcing and Roanoke-based The Tiny Cargo Company inked a strategic collaboration to co‑develop orally delivered monoclonal antibody (mAb)-based therapies formulated using goat ...

The recent FDA approval of teclistamab (Tecvayli) and daratumumab and hyaluronidase-fihj (Darzelex Faspro) marks a major ...

The respiratory illness RSV is still going strong in Chicago – an unusually late showing for the virus, which can strike ...

A judge suspended the CDC’s vaccine advisory committee but also said that the agency should be consulting it before making ...

Some respiratory viruses, especially RSV, are seeing a late winter to early spring surge in Wisconsin, public health experts ...

HHS has made reducing animal testing a priority over the past year. In April 2025, the FDA announced it would phase out the ...

The CDC has not updated its guidance on the childhood vaccine schedule, putting the states that signed onto Health Secretary Robert F. Kennedy Jr.'s pared-down recommendations in a tough spot. The ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today ...